Alexandra E. Irvine

1.7k total citations
46 papers, 1.3k citations indexed

About

Alexandra E. Irvine is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Alexandra E. Irvine has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Hematology and 12 papers in Oncology. Recurrent topics in Alexandra E. Irvine's work include Ubiquitin and proteasome pathways (10 papers), Blood disorders and treatments (8 papers) and Acute Myeloid Leukemia Research (8 papers). Alexandra E. Irvine is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Blood disorders and treatments (8 papers) and Acute Myeloid Leukemia Research (8 papers). Alexandra E. Irvine collaborates with scholars based in United Kingdom, United States and France. Alexandra E. Irvine's co-authors include Lisa Crawford, Brian Walker, Mary Frances McMullin, Lynn McCallum, T. C. M. Morris, Sukanya Suresh, Bernard Perbal, K. Bailie, Huib Ovaa and Dharminder Chauhan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Alexandra E. Irvine

46 papers receiving 1.2k citations

Peers

Alexandra E. Irvine
H Hirai Japan
Alison A. Bertuch United States
Hein Schepers Netherlands
Timothy Bushnell United States
Hong Mu United States
Lacramioara Ivanciu United States
Maria E. Balasis United States
H Hirai Japan
Alexandra E. Irvine
Citations per year, relative to Alexandra E. Irvine Alexandra E. Irvine (= 1×) peers H Hirai

Countries citing papers authored by Alexandra E. Irvine

Since Specialization
Citations

This map shows the geographic impact of Alexandra E. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra E. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra E. Irvine more than expected).

Fields of papers citing papers by Alexandra E. Irvine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra E. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra E. Irvine. The network helps show where Alexandra E. Irvine may publish in the future.

Co-authorship network of co-authors of Alexandra E. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra E. Irvine. A scholar is included among the top collaborators of Alexandra E. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra E. Irvine. Alexandra E. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jenkins, Michael, et al.. (2023). Racial microaggressions: Identifying factors affecting perceived severity and exploring strategies to reduce harm. Journal of Applied Social Psychology. 53(11). 1137–1150. 1 indexed citations
2.
Crawford, Lisa, Dharminder Chauhan, & Alexandra E. Irvine. (2017). HUWE1 Inhibition As a Therapeutic Strategy to Target MYC in MM. Blood. 130. 3077–3077. 1 indexed citations
3.
Crawford, Lisa, et al.. (2017). TRIM proteins in blood cancers. Journal of Cell Communication and Signaling. 12(1). 21–29. 47 indexed citations
4.
Suresh, Sukanya & Alexandra E. Irvine. (2015). The NOTCH signaling pathway in normal and malignant blood cell production. Journal of Cell Communication and Signaling. 9(1). 5–13. 34 indexed citations
5.
Crawford, Lisa & Alexandra E. Irvine. (2013). Targeting the ubiquitin proteasome system in haematological malignancies. Blood Reviews. 27(6). 297–304. 60 indexed citations
6.
McCallum, Lynn, et al.. (2011). CCN3 suppresses mitogenic signalling and reinstates growth control mechanisms in Chronic Myeloid Leukaemia. Journal of Cell Communication and Signaling. 6(1). 27–35. 15 indexed citations
7.
Crawford, Lisa, Laura Magill, Junia V. Melo, et al.. (2009). Proteasome proteolytic profile is linked to Bcr-Abl expression. Experimental Hematology. 37(3). 357–366. 16 indexed citations
8.
Irvine, Alexandra E., Bernard Perbal, & Herman Yeger. (2008). Report on the fifth international workshop on the CCN family of genes. Journal of Cell Communication and Signaling. 2(3-4). 95–100. 2 indexed citations
9.
McCallum, Lynn, Nathalie Planque, Bernard Perbal, et al.. (2006). A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood. 108(5). 1716–1723. 54 indexed citations
10.
Graham, Ciaren, Alexandra E. Irvine, Stephen McClean, et al.. (2005). Peptide Tyrosine Arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin secretions of the dusky gopher frog, Rana sevosa. Peptides. 26(5). 737–743. 16 indexed citations
11.
Magill, Laura, Brian Walker, & Alexandra E. Irvine. (2003). The Proteasome: A Novel Therapeutic Target in Haematopoietic Malignancy. Hematology. 8(5). 275–283. 5 indexed citations
12.
13.
Cross, L. J. M., Alexandra E. Irvine, Terence R.J. Lappin, et al.. (2001). Peptide Leucine Arginine, a Potent Immunomodulatory Peptide Isolated and Structurally Characterized from the Skin of the Northern Leopard Frog, Rana pipiens. Journal of Biological Chemistry. 276(13). 10145–10152. 41 indexed citations
14.
McMullin, Mary Frances, et al.. (2000). High bax expression is a good prognostic indicator in acute myeloid leukaemia. British Journal of Haematology. 111(1). 182–189. 54 indexed citations
15.
Bailie, K., Alexandra E. Irvine, J. M. Bridges, & B. G. McClure. (1994). Granulocyte and Granulocyte-Macrophage Colony-Stimulating Factors in Cord and Maternal Serum at Delivery. Pediatric Research. 35(2). 164–168. 42 indexed citations
16.
Irvine, Alexandra E., et al.. (1994). Drug‐induced neutropenia due to direct effects on CFU‐C — Ten years of culture experience. European Journal Of Haematology. 52(1). 21–27. 11 indexed citations
17.
Delgado, Cristina, Manuel Dómine, M. Cristina Tejedor, et al.. (1992). Polyethylene glycol (PEG) modification of granulocyte‐macrophage colony stimulating factor (GM‐CSF) enhances neutrophil priming activity but not colony stimulating activity. British Journal of Haematology. 82(4). 654–663. 30 indexed citations
18.
Morris, T. C. M., P. C. Vincent, G. A. R. Young, et al.. (1989). CFU-GM inhibitors in neutropenia. Clinical & Laboratory Haematology. 11(1). 31–45. 2 indexed citations
19.
Irvine, Alexandra E., et al.. (1985). Amoxycillin induced pancytopenia.. BMJ. 290(6473). 968–969. 3 indexed citations
20.
Irvine, Alexandra E., et al.. (1983). Ticarcillin-Induced Neutropenia Corroborated by in vitro CFU-C Toxicity. Acta Haematologica. 70(6). 364–368. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026